HealthCentral Top Site Award

sponsored by


Endsleigh offer competitive
Life Insurance policies

Calendar

«« Jul 2007 »»
S M T W T F S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Search Box

LinkBlog

Switching between monoamine oxidase inhibitors (MAOIs) and SSRI or tricyclic antidepressants (.doc format)

Switching between tricyclic, SSRI and related antidepressants (.doc format)

Gateway to PTSD information

Smoking, giving up and mental health - doses of some psych drugs may need to be adjusted

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition


No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 795,307
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Bloggapedia - Find It!

18 July 2007



Hereditary gene variation linked to premenstrual depression

Wednesday, 18 July 2007 9:15 A GMT+01
specific genetic variation may be tied to an increased risk for severe premenstrual depression or premenstrual dysphoric disorder researchers at the University of North Carolina at Chapel Hill and the National Institute of Mental Health have found.
Category: MSM

FDA safety label changes for lorazepam (Ativan®) and fluoxetine (Sarafem®)

Wednesday, 18 July 2007 8:59 A GMT+01
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has approved safety label changes for lorazepam (Ativan®) and fluoxetine (Sarafem®).

FDA agrees to priority review of ABILIFY® for depression

Wednesday, 18 July 2007 8:52 A GMT+01
The U.S. Food and Drug Administration (FDA) has granted a Priority Review for ABILIFY® (aripiprazole) for the treatment of adults with major depressive disorder as an adjunct to antidepressant therapy.